Literature DB >> 29629596

Spinal tuberculosis: review of current management.

R N Dunn1, M Ben Husien1.   

Abstract

Tuberculosis (TB) remains endemic in many parts of the developing world and is increasingly seen in the developed world due to migration. A total of 1.3 million people die annually from the disease. Spinal TB is the most common musculoskeletal manifestation, affecting about 1 to 2% of all cases of TB. The coexistence of HIV, which is endemic in some regions, adds to the burden and the complexity of management. This review discusses the epidemiology, clinical presentation, diagnosis, impact of HIV and both the medical and surgical options in the management of spinal TB. Cite this article: Bone Joint J 2018;100-B:425-31.

Entities:  

Keywords:  HIV; Review; Spine; Tuberculosis

Mesh:

Year:  2018        PMID: 29629596     DOI: 10.1302/0301-620X.100B4.BJJ-2017-1040.R1

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  38 in total

1.  Evaluation of the efficacy of OLIF combined posterior internal fixation for single-segment lumbar tuberculosis: a single-center retrospective cohort study.

Authors:  Xing Du; Yunsheng Ou; Wei Luo; Guanyin Jiang; Wanyuan Qin; Yong Zhu
Journal:  BMC Surg       Date:  2022-02-13       Impact factor: 2.102

2.  [Comparison of nano-hydroxyapatite/polyamide 66 bioactive support and autologous iliac bone in bone grafting and fusion for elderly patients with lumbar tuberculosis].

Authors:  Jiekai Ye; Jun Fei; Zhen Lai; Peng Zhang; Jinping Hu; Shengping Hu; Chenwei Zhang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-03-15

3.  Posterior limited unilateral fenestration approach for treating patients with single-segment thoracic and lumbar tuberculosis.

Authors:  Xiaolong Sheng; Zhu Guo; Zhansheng Deng; Liyuan Jiang; Jianzhong Hu
Journal:  Acta Neurochir (Wien)       Date:  2022-09-07       Impact factor: 2.816

4.  Monocyte-to-Lymphocyte Ratio Was an Independent Factor of the Severity of Spinal Tuberculosis.

Authors:  Liyi Chen; Chong Liu; Tuo Liang; Zhen Ye; Shengsheng Huang; Jiarui Chen; Xuhua Sun; Ming Yi; Jie Jiang; Tianyou Chen; Hao Li; Wuhua Chen; Hao Guo; Yuanlin Yao; Shian Liao; Chaojie Yu; Shaofeng Wu; Binguang Fan; Zhaoping Gan; Xinli Zhan
Journal:  Oxid Med Cell Longev       Date:  2022-05-20       Impact factor: 7.310

5.  [Application of small incision approach in anterior surgery of thoracic and lumbar spinal tuberculosis].

Authors:  Jiandang Shi; Jinwen He; Ningkui Niu; Zongqiang Yang; Haifeng Yuan; Huiqiang Ding
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-06-15

6.  [Treatment of lumbar tuberculosis with percutaneous pedicle screw internal fixation and minimally invasive lateral small incisions lesion debridement and bone graft fusion via dilated channels].

Authors:  Xiaoming Chen; Jingjing Leng; Guoping Liu; Xiaojun Tang; Jie Zhang; Aijun Wang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-01-15

Review 7.  Imaging update in spinal tuberculosis.

Authors:  Vijay Kubihal; Raju Sharma; R G Krishna Kumar; S H Chandrashekhara; Rakesh Garg
Journal:  J Clin Orthop Trauma       Date:  2021-12-09

8.  Application of Oblique Lateral Interbody Fusion in Treatment of Lumbar Spinal Tuberculosis in Adults.

Authors:  Quan-Kui Zhuang; Wei Li; Yong Chen; Liang Bai; Yong Meng; Yang Li; Yu-Tong Gu
Journal:  Orthop Surg       Date:  2021-05-06       Impact factor: 2.071

9.  Tubercular longitudinally extensive transverse myelitis (LETM): An enigma for primary care physicians.

Authors:  Kumar Abhishek Anand; Kalyan Kumar Bhowmik; Amit Sarkar; Ritwik Ghosh; Arpan Mandal; Bikash Swaika; Biman Kanti Ray
Journal:  J Family Med Prim Care       Date:  2021-02-27

10.  A Scoring System for Outpatient Orthopedist to Preliminarily Distinguish Spinal Metastasis from Spinal Tuberculosis: A Retrospective Analysis of 141 Patients.

Authors:  Xing Du; Yuxiao She; Yunsheng Ou; Yong Zhu; Wei Luo; Dianming Jiang
Journal:  Dis Markers       Date:  2021-05-29       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.